Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease

Aims. Current study was aimed to identify symptoms and risk factors for depression and anxiety and to estimate quality of life (QoL) in patients with diabetes mellitus type 2 (T2DM) and cerebrovascular disease (CVD). Materials and methods. We examined 73 patients with T2DM. 1st group included 49 p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Inessa Ivanovna Dubinina, Vladimir Alexeevich Zhadnov, Svetlana Vital'evna Yankina, Alexandra Viktorovna Solov'eva
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	depressive disorders anxiety disorder diabetes mellitus type 2 cerebrovascular disease Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/cd8f228eb87245beafc98ec4f4314d91
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cd8f228eb87245beafc98ec4f4314d91
record_format	dspace
spelling	oai:doaj.org-article:cd8f228eb87245beafc98ec4f4314d912021-11-14T09:00:17ZAnxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease2072-03512072-037810.14341/2072-0351-5539https://doaj.org/article/cd8f228eb87245beafc98ec4f4314d912012-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5539https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aims. Current study was aimed to identify symptoms and risk factors for depression and anxiety and to estimate quality of life (QoL) in patients with diabetes mellitus type 2 (T2DM) and cerebrovascular disease (CVD). Materials and methods. We examined 73 patients with T2DM. 1st group included 49 patients with T2DM and CVD, 2nd group - 24 patients with T2DM and no cardiovascular pathology. The groups were not significantly different in terms of age, BMI, level of HbAlc, fasting and postprandial glycemia. All patients received antihyperglycemic and antihypertensive therapy. Anxiety and depression were diagnosed with Beck Depression Inventory and Spielberger State and Trait Anxiety Scale (SSTAS). SF-36 questionnaire was used for estimation of QoL. Results. 2nd group showed symptoms of anxiety and depressive disorders in 100% and 75% of cases, respectively. 1st group showed significantly more prominent anxiety and depression symptoms. Risk factors for anxiety and depressive disorders in patients with T2DM and CVD were found to be senior age, obesity and atherogenic dyslipidemia. Conclusion. Cardiovascular comorbidity in T2DM significantly decreases QoL, especially in aspects of physical functioning and vitality. Timely diagnostics of anxiety and depression in patients with T2DM and CVD requires development of screening and rehabilitation programs.Inessa Ivanovna DubininaVladimir Alexeevich ZhadnovSvetlana Vital'evna YankinaAlexandra Viktorovna Solov'evaEndocrinology Research Centrearticledepressive disordersanxiety disorderdiabetes mellitus type 2cerebrovascular diseaseNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 4, Pp 59-62 (2012)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	depressive disorders anxiety disorder diabetes mellitus type 2 cerebrovascular disease Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	depressive disorders anxiety disorder diabetes mellitus type 2 cerebrovascular disease Nutritional diseases. Deficiency diseases RC620-627 Inessa Ivanovna Dubinina Vladimir Alexeevich Zhadnov Svetlana Vital'evna Yankina Alexandra Viktorovna Solov'eva Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
description	Aims. Current study was aimed to identify symptoms and risk factors for depression and anxiety and to estimate quality of life (QoL) in patients with diabetes mellitus type 2 (T2DM) and cerebrovascular disease (CVD). Materials and methods. We examined 73 patients with T2DM. 1st group included 49 patients with T2DM and CVD, 2nd group - 24 patients with T2DM and no cardiovascular pathology. The groups were not significantly different in terms of age, BMI, level of HbAlc, fasting and postprandial glycemia. All patients received antihyperglycemic and antihypertensive therapy. Anxiety and depression were diagnosed with Beck Depression Inventory and Spielberger State and Trait Anxiety Scale (SSTAS). SF-36 questionnaire was used for estimation of QoL. Results. 2nd group showed symptoms of anxiety and depressive disorders in 100% and 75% of cases, respectively. 1st group showed significantly more prominent anxiety and depression symptoms. Risk factors for anxiety and depressive disorders in patients with T2DM and CVD were found to be senior age, obesity and atherogenic dyslipidemia. Conclusion. Cardiovascular comorbidity in T2DM significantly decreases QoL, especially in aspects of physical functioning and vitality. Timely diagnostics of anxiety and depression in patients with T2DM and CVD requires development of screening and rehabilitation programs.
format	article
author	Inessa Ivanovna Dubinina Vladimir Alexeevich Zhadnov Svetlana Vital'evna Yankina Alexandra Viktorovna Solov'eva
author_facet	Inessa Ivanovna Dubinina Vladimir Alexeevich Zhadnov Svetlana Vital'evna Yankina Alexandra Viktorovna Solov'eva
author_sort	Inessa Ivanovna Dubinina
title	Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
title_short	Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
title_full	Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
title_fullStr	Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
title_full_unstemmed	Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
title_sort	anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
publisher	Endocrinology Research Centre
publishDate	2012
url	https://doaj.org/article/cd8f228eb87245beafc98ec4f4314d91
work_keys_str_mv	AT inessaivanovnadubinina anxietyanddepressivedisordersinpatientswithdiabetesmellitustype2andcerebrovasculardisease AT vladimiralexeevichzhadnov anxietyanddepressivedisordersinpatientswithdiabetesmellitustype2andcerebrovasculardisease AT svetlanavitalevnayankina anxietyanddepressivedisordersinpatientswithdiabetesmellitustype2andcerebrovasculardisease AT alexandraviktorovnasoloveva anxietyanddepressivedisordersinpatientswithdiabetesmellitustype2andcerebrovasculardisease
_version_	1718429614990163968

Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease

Ejemplares similares